The living-history museum in Fishers is making plans for a larger exhibit that is expected to open in 2029 and better tell ...

The CityWay development opened in 2013 and transformed what was once a parking lot near Eli Lilly and Co. into a bustling ...

The holding company also owns the nearly six-acre parking lot next to the Virginia ... The state also secured more project commitments from Eli Lilly and Co., bringing the drug giant’s total ...

Eli Lilly's diverse portfolio shows broad growth, with significant contributions from oncology and other therapeutic areas.

Eli Lilly ( LLY -6.59%) is the most valuable healthcare stock in the world, with a market capitalization of around $720 ...

I think Eli Lilly's valuation can rise a whole lot higher. While it may be down in recent months, that doesn't mean it has peaked; the stock still has a lot of upside. The Motley Fool Stock ...

It's encouraging to see that Eli Lilly has been growing its earnings per share at 16% a year over the past five years. The company is paying out a lot of its cash as a dividend, but it looks okay ...

Eli Lilly's GLP-1 market dominance, supported by superior efficacy and strong manufacturing investments, positions it as a leader alongside Novo Nordisk, with forecasted revenue growth to $75B by ...

There's still a lot to like about Eli Lilly stock, an analyst said Wednesday after the weight-loss drugs kingpin cut its sales view.

In the first half of 2024, it seemed Eli Lilly (NYSE: LLY) could do no wrong. Unfortunately, the good times didn't last very long. The stock peaked last October and was down by more than 21% when ...

2024 was an interesting year for pharmaceutical powerhouse Eli Lilly (NYSE: LLY). At one point, share prices had gained as much as 65% on the year. However, after a less-than-spectacular earnings ...